Key result
Bone and soft tissue sarcomas, representing 1% of adult cancers, require an integrated treatment approach of surgery, radiotherapy, and chemotherapy to maximize survival and quality of life.
Bone and soft tissue sarcomas are rare cancers requiring integrated treatment with surgery, radiotherapy, and chemotherapy.
Supports multidisciplinary sarcoma care pathways; leaves open prospective trials on therapy sequencing.
Bone and soft tissue sarcomas are rare, representing around 1% of all adult cancers. They mostly affect the musculoskeletal system but can metastasize, often to the lungs. Treatment involves the concerted application of surgery, radiotherapy and chemotherapy in an integrated manner to maximize survival and quality of life.
No takes yet. Share an insight, caveat, or question.
Dadia et al. (2007) studied this question. Bone and soft tissue sarcomas, representing 1% of adult cancers, require an integrated treatment approach of surgery, radiotherapy, and chemotherapy to maximize survival and quality of life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: